Noor Ul Ain Rehman
Tue, March 31, 2026 astatine 10:06 AM CDT 2 min read
Legend Biotech Corporation (NASDAQ:LEGN) besides received a standing update from Morgan Stanley connected March 11. The steadfast chopped the terms people connected the banal to $49 from $50, reiterating an Overweight standing connected the shares and telling investors that it updated estimates aft the institution released its fiscal Q4 fiscal report. It, however, added that the steadfast is awaiting further information from the CARTITUDE-5 survey and the earlier-stage successful vivo pipeline this year.
Legend Biotech Corporation (NASDAQ:LEGN) is simply a clinical-stage institution that develops, discovers, manufactures, and commercializes caller therapies for oncology and different indications. It develops precocious compartment therapies crossed an elaborate scope of exertion platforms. The institution operates successful the US, China, and different geographical segments.
While we admit the imaginable of LEGN arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.
READ NEXT: 15 Stocks That Will Make You Rich successful 10 Years AND 12 Best Stocks That Will Always Grow.
Disclosure: None. Follow Insider Monkey connected Google News.

2 hours ago
2



.png)

English (CA) ·
English (US) ·
Spanish (MX) ·